Explore diabetes
Explore obesity
Explore rare bleeding disorders
Explore growth-related disorders
Explore rare renal disorders
Explore hormone replacement therapy
Medical Information | Non-US Health Care Professionals
Prescribing Information  |  Important Safety Information
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg
Rivfloza® is indicated to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg
Rivfloza® is indicated to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

NovoCare® brochure

Download
Additional Information

We've created additional resources to address your questions.

NovoCare® brochure
NovoCare® brochure